Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.459ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.117ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.237ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.153ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.391ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.448ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.1 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.213ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.341ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.204ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.170ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.84ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.269ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.234ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Z.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.131ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.235ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used